Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Extra

Showing results (61-70 of 81) with videos related to

Pageof 9
Sort By:
European Journal of Cancer (Oxford, England : 1990)|November 30, 2000
Predictive factors of response to first-line chemotherapy in 1426 women with metastatic breast cancerM Robain, J Y Pierga, M Jouve, et al.
Bone Marrow Transplantation|February 28, 2006
Post-operative sequential high-dose chemotherapy with haematopoietic stem cell support as front-line treatment in advanced ovarian cancer: a phase II multicentre studyA Gonçalves, R Delva, M Fabbro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1995
Population pharmacokinetics and pharmacodynamics of irinotecan (CPT-11) and active metabolite SN-38 during phase I trialsG G Chabot, D Abigerges, G Catimel, et al.
European Journal of Haematology|May 1, 1991
Surgical restaging of advanced Hodgkin's disease after first line chemotherapyC Fermé, P Brice, E Bourstyn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Response to chemotherapy is a major parameter-influencing long-term survival of metastatic breast cancer patientsJ Y Pierga, M Robain, M Jouve, et al.
European Journal of Cancer Care|November 11, 2011
Tailored chemotherapy based on tumour gene expression analysis: breast cancer patients' misinterpretations and positive attitudesI Pellegrini, M Rapti, J-M Extra, et al.
Haematology and Blood Transfusion|January 1, 1987
Treatment of adult acute lymphoblastic leukemia. Preliminary results of a trial from the French GroupD Fière, E Archimbaud, J M Extra, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|January 21, 1982
[An empirical combination of antibiotics used in aplasias during chemotherapy for acute malignant hemopathies (author's transl)]D Fiere, H Vuvan, D Guyotat, et al.
Cancer Treatment Reports|February 1, 1986
Intensive timed chemotherapy protocol for 37 resistant or relapsing acute myeloid leukemiasD Fière, L Campos, H V Van, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2006
A phase II study of a paclitaxel and oxaliplatin combination in platinum-sensitive recurrent advanced ovarian cancer patientsP Viens, T Petit, A Yovine, et al.
Pageof 9

Showing results (61-70 of 81) with videos related to

Sort By:
Pageof 9
European Journal of Cancer (Oxford, England : 1990)|November 30, 2000
Predictive factors of response to first-line chemotherapy in 1426 women with metastatic breast cancerM Robain, J Y Pierga, M Jouve, et al.
Bone Marrow Transplantation|February 28, 2006
Post-operative sequential high-dose chemotherapy with haematopoietic stem cell support as front-line treatment in advanced ovarian cancer: a phase II multicentre studyA Gonçalves, R Delva, M Fabbro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1995
Population pharmacokinetics and pharmacodynamics of irinotecan (CPT-11) and active metabolite SN-38 during phase I trialsG G Chabot, D Abigerges, G Catimel, et al.
European Journal of Haematology|May 1, 1991
Surgical restaging of advanced Hodgkin's disease after first line chemotherapyC Fermé, P Brice, E Bourstyn, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 13, 2001
Response to chemotherapy is a major parameter-influencing long-term survival of metastatic breast cancer patientsJ Y Pierga, M Robain, M Jouve, et al.
European Journal of Cancer Care|November 11, 2011
Tailored chemotherapy based on tumour gene expression analysis: breast cancer patients' misinterpretations and positive attitudesI Pellegrini, M Rapti, J-M Extra, et al.
Haematology and Blood Transfusion|January 1, 1987
Treatment of adult acute lymphoblastic leukemia. Preliminary results of a trial from the French GroupD Fière, E Archimbaud, J M Extra, et al.
La Semaine Des Hopitaux : Organe Fonde Par L'Association D'Enseignement Medical Des Hopitaux De Paris|January 21, 1982
[An empirical combination of antibiotics used in aplasias during chemotherapy for acute malignant hemopathies (author's transl)]D Fiere, H Vuvan, D Guyotat, et al.
Cancer Treatment Reports|February 1, 1986
Intensive timed chemotherapy protocol for 37 resistant or relapsing acute myeloid leukemiasD Fière, L Campos, H V Van, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 28, 2006
A phase II study of a paclitaxel and oxaliplatin combination in platinum-sensitive recurrent advanced ovarian cancer patientsP Viens, T Petit, A Yovine, et al.
Pageof 9